Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK NICE Review Needs To Be More Than A ‘Bureaucratic Exercise’

Executive Summary

A review of UK HTA body NICE’s methods for appraising medicines will probably be constrained by budget considerations, but it should still aim to bring positive change, said Leslie Galloway of the Ethical Medicines Industry Group.

You may also be interested in...



Brexit Issues Lead NICE To Delay Methods Review

England’s health technology appraisal body, NICE, and the UK medicines regulator, the MHRA, are working together to align their process timelines so that access to medicines is “maintained and enhanced.”

UK Politicians Want NICE To Use Conditional Reimbursement

A UK parliamentary report has called for the HTA body NICE to consider the use of conditional reimbursement recommendations and more flexible cost-effectiveness thresholds in its ongoing methods review.

NICE Expands On Methods Review Details

UK health technology appraisal body NICE has released more details about its forthcoming review of the methods it uses for developing guidance on medicines and medical devices.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS125500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel